Abstract:Background: Bladder cancer (BLCA) has a high rate of morbidity and mortality, and is considered as one of the most malignant tumors of the urinary system. Tumor cells interact with surrounding interstitial cells, playing a key role in carcinogenesis and progression, which is partly mediated by chemokines. CXC chemokines exert anti-tumor biological roles in the tumor microenvironment and affect patient prognosis. Nevertheless, their expression and prognostic values patients with BLCA remain unclear. Methods: We used online tools, including Oncomine, UALCAN, GEPIA, GEO databases, cBioPortal, GeneMANIA, DAVID 6.8, Metascape, TRUST (version 2.0), LinkedOmics, TCGA, and TIMER2.0 to perform the relevant analysis. Results: The mRNA levels of C-X-C motif chemokine ligand (CXCL)1, CXCL5, CXCL6, CXCL7, CXCL9, CXCL10, CXCL11, CXCL13, CXCL16, and CXCL17 were increased significantly increased, and those of CXCL2, CXCL3, and CXCL12 were decreased significantly in BLCA tissues as assessed using the Oncomine, TCGA, and GEO databases. GEO showed that high levels of CXCL1, CXCL6, CXCL10, CXCL11, and CXCL13 mRNA expression are associated significantly with the poor overall survival (all p < 0.05), and similarly, those of CXCL2 and CXCL12 in the TCGA database (p < 0.05). The predominant signaling pathways involving the differentially expressed CXC chemokines are cell cycle, chemokine, and cytokine-cytokine receptor interaction. Moreover, transcription factors such as Sp1 transcription factor (SP1), nuclear factor kappa B subunit 1 (NFKB1), and RELA proto-oncogene, NF-KB subunit (RELA) were likely play critical roles in regulating CXC chemokine expression. LYN proto-oncogene, src family tyrosine kinase (LYN) and LCK proto-oncogene, src family tyrosine kinase (LCK) were identified as the key targets of these CXC chemokines. MicroRNAs miR200 and miR30 were identified as the main microRNAs that interact with several CXC chemokines through an miRNA-target network. The expression of these chemokines is closely associated with the infiltration of six categories of immune cells. Conclusion: We explored the CXC chemokines superfamily-based biomarkers associated with BLCA prognosis using public databases, and provided possible chemokine targets for patients with BLCA.

Mir-19A-3p Promotes Tumor-Relevant Behaviors in Bladder Urothelial Carcinoma Via Targeting THBS1

MiRNA‐516a Promotes Bladder Cancer Metastasis by Inhibiting MMP9 Protein Degradation Via the AKT/FOXO3A/SMURF1 Axis

Oncogenic Role of MIR516A in Human Bladder Cancer Was Mediated by Its Attenuating PHLPP2 Expression and BECN1-dependent Autophagy.

MiR-362-5p, Which is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI

LncRNA CASC15 Functions As an Oncogene by Sponging Mir-130B-3p in Bladder Cancer.

TRPM2-AS Promotes Bladder Cancer by Targeting miR-22-3p and Regulating GINS2 mRNA Expression

Oncogene Mir-187-5p is Associated with Cellular Proliferation, Migration, Invasion, Apoptosis and an Increased Risk of Recurrence in Bladder Cancer.

Overexpression of Mirna-93-5p Promotes Proliferation and Migration of Bladder Urothelial Carcinoma Via Inhibition of KLF9

Role Of Mir-1 And Its Potential Regulation Of Signaling Pathways In Bladder Cancer: A Comprehensive Investigation Based On Tcga, Geo, Arrayexpress, And Bioinformatics Analysis

LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer

MicroRNA-143 As a Tumor Suppressor for Bladder Cancer.

A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer

Mir-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells

Urinary exosomal miR-17-5p accelerates bladder cancer invasion by repressing its target gene ARID4B and regulating the immune microenvironment

Overexpression of Mir-340 Inhibits Cell Proliferation and Induces Apoptosis of Human Bladder Cancer Via Targeting Glut-1

Role of Downregulated Mir-133A-3p Expression in Bladder Cancer: a Bioinformatics Study

Comprehensive Investigation of Aberrant Microrna Profiling in Bladder Cancer Tissues.

Genetic Alteration and Prospective Signaling Pathways of Mir-517 A-3 P in Bladder Cancer : a Study Based on Mirna Sequencing Data and Bioinformatics Methods

MicroRNA-494-3p facilitates the progression of bladder cancer by mediating the KLF9/RGS2 axis

Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines

Mir-19A Correlates with Poor Prognosis of Clear Cell Renal Cell Carcinoma Patients Via Promoting Cell Proliferation and Suppressing PTEN/SMAD4 Expression.